Clinical Trials Logo

Clinical Trial Summary

Summary:

- Study title: Effects of Nebivolol on subclinical left ventricular dysfunction. A comparative study against Metoprolol. (ENESYS study)

- Study phase: 3

- Study design (parallel, cross-over, etc.), randomisation and blinding procedures, type of control (placebo or active): randomised, parallel, active-controlled, open label

- Study treatment(s)/drug(s): Nebivolol versus Metoprolol

- Patients:

- characteristics: patients with hypertension and left ventricular hypertrophy

- planned total number: 50

- Study duration:

- total enrolment period (months): 18

- treatment period (months): 6

- follow up period (months): 6

- Total study duration (months): 24

- Number of Centres: 1

- Country(ies): Romania (RO)


Clinical Trial Description

STUDY OBJECTIVES

1. PRIMARY:

- Longitudinal myocardial velocities at rest (assessed by tissue Doppler echocardiography)

- Systolic functional reserve (calculated as the absolute and relative increase of the myocardial systolic velocities at peak stress from rest)

- Brain natriuretic peptide (BNP, NT-pro BNP) after a 6-months period of treatment with nebivolol versus metoprolol. An improvement of more than 20% of the myocardial resting velocities of systolic functional reserve is considered to be clinically relevant. The working hypothesis is that the improvement of subclinical left ventricular dysfunction after 6 months of treatment is going to be greater in patients who receive nebivolol than in those who receive metoprolol.

2. SECONDARY:

- Global systolic function (ejection fraction)

- Radial myocardial velocities

- Right ventricular function

- Global diastolic function

- Left ventricular mass index ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00942487
Study type Interventional
Source Berlin-Chemie Menarini
Contact
Status Completed
Phase Phase 3
Start date April 2005
Completion date July 2009